Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice
-
- Michael Fralick
- Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Sinai Health System and University of Toronto, Toronto, Ontario, Canada (M.F.)
-
- Michael Colacci
- Sinai Health System and University of Toronto, Toronto, Ontario, Canada (M.C.)
-
- Sebastian Schneeweiss
- Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (S.S., K.F.H., K.J.L., J.J.G.)
-
- Krista F. Huybrechts
- Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (S.S., K.F.H., K.J.L., J.J.G.)
-
- Kueiyu Joshua Lin
- Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (S.S., K.F.H., K.J.L., J.J.G.)
-
- Joshua J. Gagne
- Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (S.S., K.F.H., K.J.L., J.J.G.)
書誌事項
- タイトル別名
-
- A Cohort Study
収録刊行物
-
- Annals of Internal Medicine
-
Annals of Internal Medicine 172 (7), 463-, 2020-03-10
American College of Physicians
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360861292472598784
-
- DOI
- 10.7326/m19-2522
-
- ISSN
- 00034819
-
- データソース種別
-
- Crossref